E Melchior

823 total citations
10 papers, 634 citations indexed

About

E Melchior is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, E Melchior has authored 10 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in E Melchior's work include RNA and protein synthesis mechanisms (3 papers), Bacterial Genetics and Biotechnology (2 papers) and Antimicrobial Peptides and Activities (2 papers). E Melchior is often cited by papers focused on RNA and protein synthesis mechanisms (3 papers), Bacterial Genetics and Biotechnology (2 papers) and Antimicrobial Peptides and Activities (2 papers). E Melchior collaborates with scholars based in United States. E Melchior's co-authors include Alice H. Lin, Keith R. Marotti, Robert W. Murray, Maged F. Nageh, Arthur L. Beaudet, Daniel C. Bullard, Steven Swaney, Dean L. Shinabarger, K.R. Marotti and William F. Demyan and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Arteriosclerosis Thrombosis and Vascular Biology and The Journal Of Hand Surgery.

In The Last Decade

E Melchior

10 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Melchior United States 7 216 198 165 122 111 10 634
Katsuhisa Nakata Japan 15 204 0.9× 96 0.5× 128 0.8× 147 1.2× 8 0.1× 28 710
Tiansheng Wang United States 16 400 1.9× 192 1.0× 64 0.4× 124 1.0× 30 0.3× 54 899
Yasunori Muramatsu Japan 16 433 2.0× 139 0.7× 66 0.4× 71 0.6× 18 0.2× 54 713
Paula E. Scarborough United States 11 315 1.5× 191 1.0× 86 0.5× 40 0.3× 33 0.3× 15 877
M Raymond Canada 11 490 2.3× 214 1.1× 41 0.2× 128 1.0× 10 0.1× 13 1.2k
Jutaro Tadano Japan 12 147 0.7× 38 0.2× 78 0.5× 33 0.3× 30 0.3× 41 490
Jacques Bauer Switzerland 17 184 0.9× 20 0.1× 272 1.6× 73 0.6× 33 0.3× 31 804
Cindy Wang United States 12 528 2.4× 358 1.8× 39 0.2× 279 2.3× 13 0.1× 26 1.0k
Imran H. Chowdhury India 19 353 1.6× 183 0.9× 119 0.7× 237 1.9× 7 0.1× 37 1.2k
M Tanaka Japan 13 228 1.1× 108 0.5× 49 0.3× 188 1.5× 4 0.0× 23 689

Countries citing papers authored by E Melchior

Since Specialization
Citations

This map shows the geographic impact of E Melchior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Melchior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Melchior more than expected).

Fields of papers citing papers by E Melchior

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Melchior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Melchior. The network helps show where E Melchior may publish in the future.

Co-authorship network of co-authors of E Melchior

This figure shows the co-authorship network connecting the top 25 collaborators of E Melchior. A scholar is included among the top collaborators of E Melchior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Melchior. E Melchior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Stiff, Cory M., David R. Graber, Atli Thorarensen, et al.. (2007). Bacterial translation inhibitors, 1-acylindazol-3-ols as anthranilic acid mimics. Bioorganic & Medicinal Chemistry Letters. 18(23). 6293–6297. 9 indexed citations
2.
Ruble, J. Craig, Keith R. Marotti, E Melchior, et al.. (2007). Structure–activity relationships of bioisosteres of a carboxylic acid in a novel class of bacterial translation inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(14). 4040–4043. 18 indexed citations
3.
Larsen, Scott D., J. Craig Ruble, Donna L. Romero, et al.. (2006). Discovery and initial development of a novel class of antibacterials: Inhibitors of Staphylococcus aureus transcription/translation. Bioorganic & Medicinal Chemistry Letters. 16(24). 6173–6177. 21 indexed citations
4.
Murray, Robert W., et al.. (2001). Staphylococcus aureus Cell Extract Transcription-Translation Assay: Firefly Luciferase Reporter System for Evaluating Protein Translation Inhibitors. Antimicrobial Agents and Chemotherapy. 45(6). 1900–1904. 45 indexed citations
5.
Nageh, Maged F., Keith R. Marotti, Alice H. Lin, et al.. (1997). Deficiency of Inflammatory Cell Adhesion Molecules Protects Against Atherosclerosis in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 17(8). 1517–1520. 229 indexed citations
6.
Shinabarger, Dean L., K.R. Marotti, Robert W. Murray, et al.. (1997). Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrobial Agents and Chemotherapy. 41(10). 2132–2136. 292 indexed citations
7.
Melchior, E, et al.. (1985). Mycobacterium terrae tenosynovitis. The Journal Of Hand Surgery. 10(5). 730–732. 16 indexed citations
8.
Metz, Robert, et al.. (1979). [Cross sensitivity between aminoside antibiotics (author's transl)].. PubMed. 106(8-9). 683–9. 2 indexed citations
9.
Melchior, E. (1953). [Volvulus of sigmoid, resection and emetine].. PubMed. 95(4). 137–8. 1 indexed citations
10.
Melchior, E. (1951). [Therapeutic significance of emetine in severe surgical infections].. PubMed. 270. 417–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026